Independent of activity level, muscle mass declines with age; approximately 1.25%Iyr j1 after age 35 yr. Muscle mass is directly related to peak strength but not necessarily to performance. There is an accelerated decline in peak strength after age 70 yr. Muscle power is lost at a greater rate than endurance capacity. Rates of decline of strength and performance are similar between men and women. There are genetic, chronologic, hormonal, nutritional, and behavioral (exercise) components to muscle aging. Resistance training (RT) may modify age-related changes.
Physiology/pathophysiology
Decrease in strength is due to: ) Decreased cross-sectional area (CSA) of type II (fast-twitch) muscle fibers (quality and quantity). With aging, the ratio of the CSA of type II to type I changes from 1:1 to 1:2 ) Decrease in contractile rate of force development, the ability to rapidly reach a given magnitude of muscle force during the initial phase of rising muscle force. Sarcopenia, age-associated loss of muscle mass, is usually characterized by the replacement of muscle fibers with fat and fibrosis. ) Contributing factors include disuse, metabolic, neuromusculoskeletal, and neurovascular conditions. ) Associated with functional decline often manifest in decreased knee extensor strength, postural imbalance, and decreased ability to safely navigate stairs and chairs. ) Increased fat infiltration is associated with glucose intolerance, diabetes mellitus, poor knee extensor strength, decreased muscle contractility, muscle fiber recruitment, and muscle metabolism.
Treatment
Age-related declines in strength can be delayed or diminished by consistent RT that slows the decline of muscle mass and strength more effectively than aerobic training (AT).
The effects of consistent RT include the following: ) Delayed type II muscle fibers changes ) Increases in muscle strength ) Greater power per muscle volume Other effects of consistent RT: ) Decline in fat-free mass, increase in total body mass, reduction in oxidative stress ) Increased basal metabolic rate ) Improved insulin sensitivity and glycemic control ) Increase in bone mineral density It is essential that the team physician understand:
There is an age-related decline in muscle mass and strength. RT modifies these declines, and this should be recommended. RT also modifies effects of other age-related medical conditions.
It is desirable that the team physician Understand and implement an RT program

Cardiovascular Considerations
General considerations
Regular exercise (aerobic, strength) may lower risk of fatal and nonfatal myocardial infarction, hypertension, and atherosclerotic heart disease. However, vigorous physical exertion may trigger myocardial infarction or sudden cardiac death in individuals with underlying heart disease. The risk of sudden death associated with high-intensity exercise is imprecise, but it increases with age. The benefits of regular exercise outweigh the risks. Treatment should be individualized based on cardiac condition. Use of cardiac medications is common in this age group. ) Medications can affect physical and cognitive performance; adverse effects should be considered. ) Athletes on anticoagulant medication should be counseled about the risks of sports participation, particularly contact and/or collision sports. Consistent RT may have a beneficial effect on cardiovascular health.
Physiology
Age-related changes include the following: ) Increased peripheral vascular resistance; regular exercise decreases peripheral vascular resistance ) Decreased V O 2max h V O 2max declines at the rate of about 10% per decade beyond age 25 yr; it declines steeply after age 60 yr.
by the American College of Sports Medicine. Unauthorized reproduction of this article is prohibited. Copyright @ 2010 h With regular exercise, the decline may be as much as half the rate in master athletes as compared with nonathletes. ) Decreased cardiac output; exercise lessens this decrease ) Decreased ventilatory anaerobic threshold; exercise lessens ventilatory anaerobic threshold decrease The effects of consistent RT on cardiovascular physiology include the following: ) Decreased blood pressure ) Decreased resting HR ) Improved left ventricular function
Cardiovascular conditions
Sudden cardiac death
Most sudden cardiac death is caused by atherosclerotic CAD. Other less common conditions that predispose to sudden death include the following: ) Hypertrophic cardiomyopathy (HCM) ) Valvular heart disease ) Dilated cardiomyopathies ) Myocarditis ) Dysrhythmias and conduction abnormalities Refer to ''Mass participation event management for the team physician: a consensus statement'' [Med Sci Sports Exerc. 2004; 36(11):2004-8] for equipment and medical supplies related to arrhythmias and managing individuals presenting with sudden cardiac arrest.
Atherosclerotic CAD
The most common cardiac disease in this age group and major risk factor for angina, myocardial infarction, and arrhythmia. Acute myocardial infarction occurs in individuals even with minimal coronary artery stenosis.
Treatment
Individuals with documented CAD (950% narrowing if angiography has been performed) should not participate in high-intensity sports/activities without further consultation because of increased risk of myocardial infarction and sudden cardiac death. 
Athletes with prehypertension and stage 1 hypertension in the absence of target organ damage should not be restricted from participation in master activities.
Athletes with stage 2 hypertension should be restricted from static high-resistance sports (e.g., weight training) and should likely be restricted from high-intensity sports until their blood pressure is normalized. 
Congenital and valvular heart disease conditions
Treatment
Individuals with controlled atrial fibrillation can participate in sport or activity.
Evaluation
Refer to Table 1 . Moderate-to high-risk profiles for CAD include men older than 40 yr and women older than 50 yr or postmenopausal with one or more independent coronary risk factors (hyperlipidemia or dyslipidemia, systemic hypertension, cigarette smoking, diabetes mellitus, family history of premature CAD). Both should have symptomlimited ECG exercise testing.
It is essential that the team physician understand:
The most common cause for sudden death in master athletes is atherosclerotic CAD. The indications for exercise ECG testing. The effects and adverse effects of cardiovascular medications on health and performance. When to restrict activity or participation among master athletes with cardiovascular issues. Automatic external defibrillators should be available at all sanctioned masters sporting events, along with personnel trained in cardiopulmonary resuscitation.
It is desirable that the team physician understand:
How to manage medications in the master athlete with cardiovascular disease. Age-related cardiovascular determinants of exercise performance, such that guidelines may be given for exercise training.
Preparticipation Evaluation (PPE)
General considerations A PPE should be performed periodically for the athlete who is participating in a vigorous exercise.
The PPE should emphasize the cardiovascular, musculoskeletal, and neurologic systems and be specific to both the individual athlete and his/her sport or activities. 
Physical examination
Complete physical examination with emphasis on cardiac, neurological, and musculoskeletal systems or as directed by history Cardiovascular (see previous section) Musculoskeletal ) Spine and joint examination as directed by sport/ activity Neurologic examination ) Strength and sensation upper and lower extremity ) Reflexes ) Balance and proprioception Additional testing to consider dependent on history and physical examination
Clearance issues
Cleared without restrictions Cleared pending further testing or evaluation (additional testing, consultations, follow-up BP, etc.) Cleared with restrictions (e.g., collision/contact sports, load-bearing activities, vigorous activity) Not cleared for participation
Return-to-play issues
See ''The team physician and return-to-play issues: a consensus statement'' [Med Sci Sports Exerc. 2002; 34(7):1212-4]. Is the athlete at increased risk for injury or illness? Can this risk be modified to make it acceptable (protective equipment, rehabilitation, medication)? Are other participants at risk for injury or illness because of the problem?
The primary purpose of the PPE is to identify patients at risk for cardiovascular complications of exercise, especially with occult cardiac disease. The PPE should emphasize the cardiovascular, musculoskeletal, and neurologic systems and be specific to both the individual athlete and his/her sport or activities. Perform a history and physical that clears the athlete for participation or identifies need for further evaluation or referral.
Preventive screening for chronic disease in the older athlete. Coordinate a multidisciplinary team to care for the master athlete. Additional testing to evaluate fitness and exclude cardiovascular disease, major musculoskeletal deficiencies, and neurologic/balance issues.
MUSCULOSKELETAL CONSIDERATIONS FOR THE MASTER ATHLETE Achilles Tendon Ruptures Etiologic factors
Age: There is a higher incidence older than 45 yr Fluoroquinolones: FDA Black Box Warning of increased risk Activity: Sudden changes in intensity of eccentric athletic activity, which result in tensile overload Tendon degenerative changes include the following: ) Decreased tensile strength and increased stiffness ) Decreased number of Golgi tendon receptors, which results in altered force regulation feedback to muscle
Clinical presentation
There are minimal prodromal symptoms. Painful Achilles tendons rarely rupture. Acute presentation ) Pop/snap (sensation of being struck) on sudden eccentric loading, in acceleration, deceleration ) Impaired ability to walk, to raise up on toes, or to run ) Physical examination It is desirable that the team physician know:
The pathophysiology of Achilles tendon rupture. The clinical presentation of chronic Achilles tendon rupture.
The benefits and problems associated with operative and nonoperative treatments. The content and implementation of a conditioning program for reducing the risk factors of Achilles tendon rupture.
Osteoarthritis General considerations
Degeneration of articular cartilage characterized by loss of cartilage thickness, attempted repair, remodeling, subchondral sclerosis, and osteophytes. The most common cause of musculoskeletal pain and disability.
Hip Etiologic factors
Age Obesity 
Imaging
Imaging findings alone do not dictate treatment. Plain x-rays are routine in evaluation. ) Multiplanar views: True AP (internal and external rotation), axillary, outlet MRI is rarely necessary for initial treatment; it is necessary for preoperative planning.
Treatment
In general, shoulder arthritis is well tolerated. ) There is commonly minimal significant load bearing through the joint. Modifications may be necessary in certain sports/activities that require motion above 90-.
It is essential that the team physician:
Know clinical presentation of shoulder osteoarthritis.
Understand not all shoulder joint pain is due to osteoarthritis. Understand treatment options. Conduct a comprehensive history and physical examination of the shoulder.
It is desirable that the team physician:
Interpret imaging. Implement a treatment program. Understand the pathophysiology of shoulder osteoarthritis. Suggest and implement activity modifications to allow maximum athletic participation within the limits of the arthritis.
Lumbar Spinal Stenosis (LSS) General considerations
Natural history in the absence of medical care has not been well studied. Stenosis (canal narrowing) can be central, lateral recess, neuroforaminal, or a combination. Cause of pain not completely understood. Direct compression of nerve root and disruption of vascular flow hypothesized.
Etiologic factors
Age Stenosis is usually caused by degenerative changes (disk bulging and facet and ligament hypertrophy). ) Other etiologies include disk herniation, spondylolisthesis, synovial cyst, and epidural lipomatosis.
Clinical presentation
Radiating pain from the back or buttocks into the lower extremities h Occurs with walking and is relieved by sitting or bending forward ) Also occur with prolonged standing ) Include numbness, tingling, fatigue, and weakness ) Vary based on the severity, type, and location of the stenosis (e.g., bilateral vs unilateral lower extremity symptoms and different radicular distributions) ) May wax and wane ) Progression is typically insidious, although rapid progression may occur. Physical examination ) Reproduction of lower extremity symptoms with lumbar extension ) Neurological examination is often normal.
h May have absent ankle reflexes, a common age-related finding Differential diagnosis includes vascular disease, peripheral neuropathy, hip pathology, myopathy, myelopathy, and rheumatologic disease (e.g., polymyalgia rheumatica).
Imaging/diagnostic studies
This is a radiographic diagnosis that must correlate with signs and symptoms. ) 21% of asymptomatic people aged 60 yr or older have stenosis by MRI. X-ray: Weight bearing AP and weight bearing lateral flexion/extension views Advanced imaging: Usually MRI; occasionally myelogram/CT EMG, vascular studies, and laboratory tests may also be indicated.
Nonoperative care
Appropriate for patients with mild to moderate symptoms or patients who have medical contraindications to surgery ) Does not alter the natural history ) Helps manage symptoms and maintain function Pharmacologic ) Acetaminophen is preferred. If ineffective, consider NSAID with caution. ) Oral corticosteroids with caution ) Opiates sparingly ) Antidepressants and anticonvulsants for neuropathic pain ) Fluoroscopically guided spinal injections used sparingly as an adjunct to treatment Physical therapy ) Directional preference traditionally toward flexion ) Aerobic conditioning, strength, and balance training Lumbar support for comfort only Activity modification usually emphasizing flexionbiased activities (e.g., bicycling vs running)
Operative care
Appropriate for patients with severe lower extremity symptoms and/or functional limitations without medical contraindications Decompression via laminectomy is the most frequently performed surgery. ) Fusion has been reserved for cases of stenosis with instability or, in some cases, of scoliosis and stenosis. ) Data on implantable spinous process spacers remain limited.
Understand the clinical presentation of LSS. 
Clinical presentation
This presents in a spectrum of tendinopathy, with the end point being tear. Gradual onset of tendinopathy or tear ) History of chronic ''tendonitis/bursitis'' ) Weakness/fatigue, especially in overhead/forward flexed positions ) Night pain is a dominant feature Acute onset of tear ) Posttraumatic: Most common is fall on outstretched arm ) Marked weakness to attempted forward flexion/ abduction ) Night pain Physical examination ) (+/j) Atrophy ) (+) Impingement sign and test (subacromial local anesthetic injection) ) Painful arc of motion ) Muscle weakness or pain inhibition 
